
- Pharmaceutical Commerce - January/February 2009
HealthBridge bulks up operations and compliance staff
Express Scripts subsidiary adds to pharma rep-sales support
HealthBridge is counting on attracting more business from pharma companies that want better support of their sales operations, based on the personnel announcements made recently. The company has added:
- Laura Perry as senior director, client services; Laura is a 20-year industry veteran
- Lori Maimone, as product manager, sample accountability; Lori is formerly with PDI, Inc.
- Anthony Gallirio, as senior manager, performance analysis and reporting; Anthony is formerly with IMS Health and Verispan.
“With the recent resource cutbacks in the pharmaceutical industry, pharmaceutical manufacturers are looking to outsourced service providers to fill the gaps, not only the sales and marketing front but also from a commercial operations perspective,” says Carmen Mazzetta, VP and GM of HealthBridge. The Lincoln Park, NJ, company, a subisidiary of Express Scripts, provides sample fulfillment, marketing programs, and virtual sales force programs to over 30 pharmaceutical manufacturers, and delivered 3.5 million shipments of product to practitioners, pharmaceutical sales representatives, retailers, wholesalers & pharmacies. It is supported by Phoenix Marketing Group LLC.
Articles in this issue
over 16 years ago
Closing The Circle On Patient Adherenceover 16 years ago
3PLs Rise in Forward-Thinking Supply Chain Modelsover 16 years ago
A Pitched Battle in Cardiovascular Drug Marketingover 16 years ago
Wyeth Loses Supreme Court Case Over 'Implied' Pre-Emptionover 16 years ago
Syringe Design Gets a Makeoverover 16 years ago
Refinements in Cold Chain Secondary Packagingover 16 years ago
Inmar Rebrands Reverse-Logistics and Related Business Unitsover 16 years ago
The Packaging Contribution to Patient Adherenceover 16 years ago
Moving the Dial on Patient AdherenceNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.